We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
The most commonly encountered drugs currently controlled under the misuse of drugs legislation.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Information about support for British nationals experiencing mental health difficulties in Turkey.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
A 4-year Retrospective Study at a Tertiary Cancer Center, Kerala, India
Foreign, Commonwealth & Development Office (FCDO) advice for lesbian, gay, bisexual and transgender (LGBT+) people travelling abroad.
Sanofi UK is recalling the listed batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
An investigation by the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) has led to charges being brought against five people from the Wolverhampton area for the illegal supply of prescription-only medicines and controlled drugs.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
The MHRA has re-issued this notification as Class 3 recall based on further assessment. Please note the new actions for healthcare professionals listed within the notification. Doncaster Pharma Limited have identified an error relating to the Braille printed on the...
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).